CDK4/6i are thought to work primarily by inducing cytostasis via G1 cell-cycle arrest, but have also been shown to induce apoptosis in vitro.55 Preclinical evidence suggests that CDK4/6i promote anti-tumor immunity by increasing antigen processing and presentation. Here, CDK4 is linked to neoplasm.